Option Care Health (NASDAQ:OPCH) Receives “Market Outperform” Rating from JMP Securities

JMP Securities reiterated their market outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research report released on Friday,Benzinga reports. JMP Securities currently has a $30.00 price target on the stock, down from their previous price target of $31.00.

A number of other analysts have also weighed in on OPCH. Barrington Research reduced their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial decreased their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the company from $38.00 to $26.00 in a research report on Thursday, October 31st. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health currently has a consensus rating of “Hold” and a consensus price target of $29.14.

Option Care Health Trading Down 0.6 %

NASDAQ OPCH opened at $23.99 on Friday. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock’s fifty day moving average price is $23.10 and its 200-day moving average price is $27.70. The stock has a market cap of $4.08 billion, a P/E ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. UMB Bank n.a. increased its stake in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after buying an additional 1,446 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the period. Finally, Quarry LP increased its holdings in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after acquiring an additional 2,628 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.